NCT01838174 arm group 81c892f412ee42bf1a06132b70c71976 [clinicaltrials_resource:NCT01838174/arm-group/81c892f412ee42bf1a06132b70c71976]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01838174 arm group 81c892f412ee42bf1a06132b70c71976 [clinicaltrials_resource:NCT01838174/arm-group/81c892f412ee42bf1a06132b70c71976]
Bio2RDF identifier
NCT01838174/arm-group/81c892f412ee42bf1a06132b70c71976
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... c892f412ee42bf1a06132b70c71976
description [clinicaltrials_vocabulary:description]
15 days of intramuscular (IM) or sub-cutaneous corticotropin (SQ) Acthar (ACTH).
identifier
clinicaltrials_resource:NCT01838174/arm-group/81c892f412ee42bf1a06132b70c71976
title
NCT01838174 arm group 81c892f412ee42bf1a06132b70c71976
@en
type
label
NCT01838174 arm group 81c892f4 ...... 892f412ee42bf1a06132b70c71976]
@en